AngioDynamics, Inc.
ANGO
$9.66
$0.272.88%
| Weiss Ratings | ANGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ANGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ANGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.37 | |||
| Price History | ANGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.13% | |||
| 30-Day Total Return | -6.58% | |||
| 60-Day Total Return | 5.46% | |||
| 90-Day Total Return | 41.85% | |||
| Year to Date Total Return | 7.57% | |||
| 1-Year Total Return | 65.69% | |||
| 2-Year Total Return | -22.53% | |||
| 3-Year Total Return | -55.52% | |||
| 5-Year Total Return | -3.78% | |||
| 52-Week High % Change | -29.63% | |||
| 52-Week Low % Change | 73.67% | |||
| Price | ANGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $13.50 | |||
| 52-Week Low Price | $5.47 | |||
| 52-Week Low Price (Date) | Jul 09, 2024 | |||
| 52-Week High Price (Date) | Jan 30, 2025 | |||
| Valuation | ANGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 384.42M | |||
| Enterprise Value | 335.24M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -5.58 | |||
| Earnings Per Share Growth | 1,476.04% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.36 | |||
| Price/Book (Q) | 2.08 | |||
| Enterprise Value/Revenue (TTM) | 1.17 | |||
| Price | $9.66 | |||
| Enterprise Value/EBITDA (TTM) | -29.52 | |||
| Enterprise Value/EBIT | -9.07 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | ANGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 40.92M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ANGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 518 795 1400 | |||
| Address | 14 Plaza Drive Latham, NY 12110 | |||
| Website | www.angiodynamics.com | |||
| Country | United States | |||
| Year Founded | 1988 | |||
| Profitability | ANGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -12.89% | |||
| Profit Margin | -78.43% | |||
| Management Effectiveness | ANGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -5.84% | |||
| Return on Equity | -- | |||
| Income Statement | ANGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 286.50M | |||
| Total Revenue (TTM) | 286.50M | |||
| Revenue Per Share | $7.00 | |||
| Gross Profit (TTM) | 151.01M | |||
| EBITDA (TTM) | -11.36M | |||
| EBIT (TTM) | -36.94M | |||
| Net Income (TTM) | -224.72M | |||
| Net Income Avl. to Common (TTM) | -224.72M | |||
| Total Revenue Growth (Q YOY) | -7.88% | |||
| Earnings Growth (Q YOY) | 63.03% | |||
| EPS Diluted (TTM) | -5.58 | |||
| EPS Diluted Growth (Q YOY) | 63.67% | |||
| Balance Sheet | ANGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 54.09M | |||
| Cash Per Share (Q) | $1.32 | |||
| Total Current Assets (Q) | 175.36M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 186.77M | |||
| Current Ratio (Q) | 1.979 | |||
| Book Value Per Share (Q) | $4.57 | |||
| Total Assets (Q) | 291.55M | |||
| Total Current Liabilities (Q) | 88.60M | |||
| Total Debt (Q) | 4.91M | |||
| Total Liabilities (Q) | 104.78M | |||
| Total Common Equity (Q) | 186.77M | |||
| Cash Flow | ANGO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 22.70M | |||
| Cash from Financing (TTM) | -5.94M | |||
| Net Change in Cash (TTM) | -6.81M | |||
| Levered Free Cash Flow (TTM) | 17.42M | |||
| Cash from Operations (TTM) | -23.31M | |||
